P
PT Nusantara Sawit Sejahtera Tbk
IDX:NSSS
PT Nusantara Sawit Sejahtera Tbk
IDX:NSSS
Price:
775
IDR
9.15%
Market Cap:
Rp18.4T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PT Nusantara Sawit Sejahtera Tbk
IDX:NSSS
|
ID |
|
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
|
IN |
|
Rubis SCA
LSE:0RTS
|
FR |
|
A
|
Arthur J. Gallagher & Co.
SWB:GAH
|
US |
Balance Sheet
Balance Sheet Decomposition
PT Nusantara Sawit Sejahtera Tbk
PT Nusantara Sawit Sejahtera Tbk
Balance Sheet Decomposition is not available for
PT Nusantara Sawit Sejahtera Tbk
PT Nusantara Sawit Sejahtera Tbk
Balance Sheet
PT Nusantara Sawit Sejahtera Tbk
PT Nusantara Sawit Sejahtera Tbk
Currency: IDR
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
41 536
|
191 229
|
40 453
|
242 894
|
386 397
|
|
| Cash |
41 536
|
191 229
|
40 453
|
242 894
|
386 397
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
15 437
|
23 617
|
33 457
|
37 046
|
52 000
|
|
| Accounts Receivables |
14 365
|
21 545
|
30 250
|
33 487
|
49 824
|
|
| Other Receivables |
1 072
|
2 072
|
3 207
|
3 559
|
2 176
|
|
| Inventory |
82 422
|
165 740
|
232 588
|
329 587
|
267 362
|
|
| Other Current Assets |
3 824
|
16 814
|
24 200
|
26 237
|
13 823
|
|
| Total Current Assets |
143 219
|
397 400
|
330 697
|
635 765
|
719 581
|
|
| PP&E Net |
2 485 599
|
2 456 705
|
2 469 652
|
2 719 118
|
2 675 496
|
|
| PP&E Gross |
2 485 599
|
2 456 705
|
2 469 652
|
2 719 118
|
2 675 496
|
|
| Accumulated Depreciation |
421 595
|
531 785
|
651 523
|
776 919
|
924 010
|
|
| Note Receivable |
11 653
|
20 696
|
26 571
|
77 916
|
123 085
|
|
| Other Long-Term Assets |
114 677
|
100 199
|
208 365
|
239 538
|
209 583
|
|
| Total Assets |
2 755 148
N/A
|
2 975 000
+8%
|
3 035 285
+2%
|
3 672 336
+21%
|
3 727 745
+2%
|
|
| Liabilities | ||||||
| Accounts Payable |
119 598
|
105 189
|
124 439
|
254 325
|
93 732
|
|
| Accrued Liabilities |
19 407
|
18 752
|
21 269
|
17 519
|
29 961
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
163 693
|
165 752
|
108 997
|
258 356
|
385 242
|
|
| Other Current Liabilities |
50 761
|
73 212
|
82 392
|
148 126
|
118 295
|
|
| Total Current Liabilities |
353 459
|
362 905
|
337 097
|
678 327
|
627 231
|
|
| Long-Term Debt |
2 062 312
|
1 990 081
|
1 995 605
|
1 847 377
|
1 612 550
|
|
| Deferred Income Tax |
1 275
|
40 724
|
48 603
|
56 189
|
85 349
|
|
| Minority Interest |
6
|
6
|
6
|
6
|
11
|
|
| Other Liabilities |
24 702
|
22 038
|
23 856
|
29 252
|
37 555
|
|
| Total Liabilities |
2 441 754
N/A
|
2 415 754
-1%
|
2 405 167
0%
|
2 611 152
+9%
|
2 362 697
-10%
|
|
| Equity | ||||||
| Common Stock |
1 011 000
|
1 011 000
|
1 011 000
|
1 189 443
|
1 190 078
|
|
| Retained Earnings |
699 102
|
453 250
|
382 379
|
381 946
|
80 495
|
|
| Additional Paid In Capital |
1 496
|
1 496
|
1 496
|
253 687
|
255 465
|
|
| Total Equity |
313 394
N/A
|
559 246
+78%
|
630 117
+13%
|
1 061 184
+68%
|
1 365 048
+29%
|
|
| Total Liabilities & Equity |
2 755 148
N/A
|
2 975 000
+8%
|
3 035 285
+2%
|
3 672 336
+21%
|
3 727 745
+2%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
23 788
|
23 788
|
20 220
|
23 789
|
23 802
|
|
Switch to:
Switch to:
See Also
Discover More
